Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Tumors of the Pancreatic Body and Tail.

Barreto SG, Shukla PJ, Shrikhande SV.

World J Oncol. 2010 Apr;1(2):52-65. doi: 10.4021/wjon2010.04.200w. Epub 2010 Apr 30. Review.

2.
3.

Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm.

Patra KC, Bardeesy N, Mizukami Y.

Clin Transl Gastroenterol. 2017 Apr 6;8(4):e86. doi: 10.1038/ctg.2017.3.

4.

Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas.

Pea A, Yu J, Rezaee N, Luchini C, He J, Dal Molin M, Griffin JF, Fedor H, Fesharakizadeh S, Salvia R, Weiss MJ, Bassi C, Cameron JL, Zheng L, Scarpa A, Hruban RH, Lennon AM, Goggins M, Wolfgang CL, Wood LD.

Ann Surg. 2017 Jul;266(1):133-141. doi: 10.1097/SLA.0000000000001817.

5.

Expansion of epigenetic alterations in EFEMP1 promoter predicts malignant formation in pancreatobiliary intraductal papillary mucinous neoplasms.

Yoshida K, Nagasaka T, Umeda Y, Tanaka T, Kimura K, Taniguchi F, Fuji T, Shigeyasu K, Mori Y, Yanai H, Yagi T, Goel A, Fujiwara T.

J Cancer Res Clin Oncol. 2016 Jul;142(7):1557-69. doi: 10.1007/s00432-016-2164-x. Epub 2016 Apr 19.

6.

Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma.

Rezaee N, Barbon C, Zaki A, He J, Salman B, Hruban RH, Cameron JL, Herman JM, Ahuja N, Lennon AM, Weiss MJ, Wood LD, Wolfgang CL.

HPB (Oxford). 2016 Mar;18(3):236-46. doi: 10.1016/j.hpb.2015.10.010. Epub 2015 Dec 10.

7.

Exploring the Functional Disorder and Corresponding Key Transcription Factors in Intraductal Papillary Mucinous Neoplasms Progression.

Bai G, Wu C, Gao Y, Shu G.

Int J Genomics. 2015;2015:197603. doi: 10.1155/2015/197603. Epub 2015 Sep 3.

8.

Intraductal Papillary Mucinous Neoplasm of the Pancreas: Current Perspectives.

Dumlu EG, Karakoç D, Özdemir A.

Int Surg. 2015 Jun;100(6):1060-8. doi: 10.9738/INTSURG-D-14-00220.1. Review.

9.
10.

Intraductal Papillary Mucinous Neoplasm of Pancreas.

Machado NO, Al Qadhi H, Al Wahibi K.

N Am J Med Sci. 2015 May;7(5):160-75. doi: 10.4103/1947-2714.157477. Review.

11.

Increased risk of second malignancy in pancreatic intraductal papillary mucinous tumors: Review of the literature.

Baiocchi GL, Molfino S, Frittoli B, Pigozzi G, Gheza F, Gaverini G, Tarasconi A, Ricci C, Bertagna F, Grazioli L, Tiberio GA, Portolani N.

World J Gastroenterol. 2015 Jun 21;21(23):7313-9. doi: 10.3748/wjg.v21.i23.7313. Review.

12.

Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.

Adsay V, Mino-Kenudson M, Furukawa T, Basturk O, Zamboni G, Marchegiani G, Bassi C, Salvia R, Malleo G, Paiella S, Wolfgang CL, Matthaei H, Offerhaus GJ, Adham M, Bruno MJ, Reid MD, Krasinskas A, Klöppel G, Ohike N, Tajiri T, Jang KT, Roa JC, Allen P, Fernández-del Castillo C, Jang JY, Klimstra DS, Hruban RH; Members of Verona Consensus Meeting, 2013.

Ann Surg. 2016 Jan;263(1):162-77. doi: 10.1097/SLA.0000000000001173.

13.

Pathological and molecular evaluation of pancreatic neoplasms.

Rishi A, Goggins M, Wood LD, Hruban RH.

Semin Oncol. 2015 Feb;42(1):28-39. doi: 10.1053/j.seminoncol.2014.12.004. Epub 2014 Dec 9. Review.

14.

Extent of Surgery and Implications of Transection Margin Status after Resection of IPMNs.

Paini M, Crippa S, Scopelliti F, Baldoni A, Manzoni A, Belfiori G, Partelli S, Falconi M.

Gastroenterol Res Pract. 2014;2014:269803. doi: 10.1155/2014/269803. Epub 2014 Sep 4. Review.

15.
16.

Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas.

Castellano-Megías VM, Andrés CI, López-Alonso G, Colina-Ruizdelgado F.

World J Gastrointest Oncol. 2014 Sep 15;6(9):311-24. doi: 10.4251/wjgo.v6.i9.311. Review.

17.

Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas.

Paini M, Crippa S, Partelli S, Scopelliti F, Tamburrino D, Baldoni A, Falconi M.

World J Gastroenterol. 2014 Aug 7;20(29):10008-23. doi: 10.3748/wjg.v20.i29.10008. Review.

18.

Focus on the intraductal papillary mucinous neoplasm of the pancreas.

Gallucci F, Langellotto A, De Ritis R, Uomo G.

Gastroenterol Hepatol Bed Bench. 2012 Summer;5(3):123-31. Review.

19.

Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN.

Distler M, Aust D, Weitz J, Pilarsky C, Grützmann R.

Biomed Res Int. 2014;2014:474905. doi: 10.1155/2014/474905. Epub 2014 Mar 24. Review.

20.

How severe is diabetes after total pancreatectomy? A case-matched analysis.

Roberts KJ, Blanco G, Webber J, Marudanayagam R, Sutcliffe RP, Muiesan P, Bramhall SR, Isaac J, Mirza DF.

HPB (Oxford). 2014 Sep;16(9):814-21. doi: 10.1111/hpb.12203. Epub 2013 Dec 18.

Supplemental Content

Support Center